Even if you make money, China Resources will completely withdraw from the medical device business!

China Resources wants to completely withdraw from the medical device business!

Fu Yuning, Chairman of China Resources Group

On May 21, Dong'e Ejiao Co., Ltd., a company controlled by China Resources Group, issued the “Announcement on Transferring the Equity of Dong'e Ejiao Ahua Medical Devices Co., Ltd.”, and intends to transfer 36% of Dongya Ejiao Medical Devices Co., Ltd. (hereinafter referred to as "Ahua Medical Devices") equity, the transfer amount is 295.558 million yuan, the announcement said that the transfer is in accordance with the development strategy of Dong'e Ejiao focus on blood, nourishing, health care business, intends to dispose of the medical device equity, to achieve Non-main business strategic exit.

According to public information, Iowa Medical Devices was founded in 1987 and reorganized by Dong'e Ejiao in April 2000. The newly established company has a registered capital of RMB 3,333,300 and the legal representative is Qin Yufeng, Chairman of Dong'e Ejiao. At present, the company's main business is the production and sales of glass thermometers, electronic thermometers, electronic sphygmomanometers , blood glucose meters, medical plasters, medical adhesive plasters, Dongjia Ejiao holds 36%.

According to the announcement, the operating income of Ahua Medical Devices in 2015 was 1.4266 billion yuan, the operating profit was 22.09 million yuan, the net profit was 16.91 million yuan; the total assets were 100 million yuan, the total liabilities were 64.08 million yuan, and the net assets were 37.14 million yuan.

After the reorganization in 2004, Iowa Medical Devices was based on the original business (thermometer, electronic sphygmomanometer, quartz ultraviolet germicidal lamp, wrist splint, medical adhesive plaster) (Medical Note: According to the official website, the company is China Medical Device Industry Association) The director of the glass thermometer professional committee, the production and sales volume of the glass thermometer is the first in the world. The mercury-free thermometer is the patented product developed by the company. It is the first domestic medical device production license, and the technical level is leading domestically. The rapid electronic thermometer has made breakthroughs in the development. Achieved 10 seconds of temperature measurement), its leading product thermometer production and sales ranks among the best in the same industry in the country, the domestic market share of more than 35%, its "Dongyue" brand thermometer has been rated as "2015 top ten thermometers" , along with Omron, Yuyue, Citizen, etc.

In addition, the company has also increased the development and sales of joint painkiller cream, wound moisturizing cream, and musk strong bone cream. The company developed and produced the "Ahua" brand fragrant bone paste, joint painkiller and other products. Since the market, it has been sold to more than 20 provinces and cities such as Shandong, Beijing and Liaoning.

All of the above data indicates that this is a medical device manufacturer with good products and strong profitability, but why should it be sold?

In the eyes of the industry, Dong'e Ejiao's withdrawal from the medical device industry is the result of its controlling company, China Resources Group.

According to the 2015 annual report, the total operating income of Dong'e Ejiao reached 5.45 billion yuan, and the net profit of returning to the mother was 1.625 billion yuan, up 19% year-on-year. The 143 million revenues of Iowa Medical Devices are almost minimal, which can only be said to be fractional and drizzling. At the same time, for high-level executives who want to hit higher operating income, the growth rate of medical devices is obviously too slow.

For Dong'e Ejiao, the sale of Iowa medical devices has long been planned.

Walnuts Inshell

Inner Mongolia Xuanda Food Co., Ltd. , https://www.xuandagroup.com